These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15883337)

  • 1. Effects of chronic lead exposure on 1H MRS of hippocampus and frontal lobes in children.
    Meng XM; Zhu DM; Ruan DY; She JQ; Luo L
    Neurology; 2005 May; 64(9):1644-7. PubMed ID: 15883337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic lead exposure on 1H MRS of hippocampus and frontal lobes in children.
    Mandelbaum D
    Neurology; 2006 Feb; 66(4):614; author reply 614. PubMed ID: 16505335
    [No Abstract]   [Full Text] [Related]  

  • 3. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study.
    Senaratne R; Milne AM; MacQueen GM; Hall GB
    Psychiatry Res; 2009 Jun; 172(3):205-9. PubMed ID: 19386476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders.
    Gabis L; Wei Huang ; Azizian A; DeVincent C; Tudorica A; Kesner-Baruch Y; Roche P; Pomeroy J
    J Child Neurol; 2008 Jul; 23(7):766-74. PubMed ID: 18487520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental instability and working memory ability in children: a magnetic resonance spectroscopy investigation.
    Yeo RA; Hill D; Campbell R; Vigil J; Brooks WM
    Dev Neuropsychol; 2000; 17(2):143-59. PubMed ID: 10955200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased frontal choline and neuropsychological performance in preclinical Huntington disease.
    Gómez-Ansón B; Alegret M; Muñoz E; Sainz A; Monte GC; Tolosa E
    Neurology; 2007 Mar; 68(12):906-10. PubMed ID: 17372125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
    Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased choline and creatine concentrations in centrum semiovale in patients with generalized anxiety disorder: relationship to IQ and early trauma.
    Coplan JD; Mathew SJ; Mao X; Smith EL; Hof PR; Coplan PM; Rosenblum LA; Gorman JM; Shungu DC
    Psychiatry Res; 2006 Jun; 147(1):27-39. PubMed ID: 16797939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
    Szulc A; Galinska B; Tarasow E; Dzienis W; Kubas B; Konarzewska B; Walecki J; Alathiaki AS; Czernikiewicz A
    Pharmacopsychiatry; 2005 Sep; 38(5):214-9. PubMed ID: 16189748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study.
    Frey BN; Stanley JA; Nery FG; Monkul ES; Nicoletti MA; Chen HH; Hatch JP; Caetano SC; Ortiz O; Kapczinski F; Soares JC
    Bipolar Disord; 2007 Jun; 9 Suppl 1():119-27. PubMed ID: 17543030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients.
    Gonul AS; Kitis O; Ozan E; Akdeniz F; Eker C; Eker OD; Vahip S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):120-5. PubMed ID: 16236417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
    Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A
    Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc protoporphyrin levels, blood lead levels and neurocognitive deficits in Andean children with chronic lead exposure.
    Counter SA; Buchanan LH; Ortega F
    Clin Biochem; 2008 Jan; 41(1-2):41-7. PubMed ID: 18035344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study.
    Port JD; Unal SS; Mrazek DA; Marcus SM
    Psychiatry Res; 2008 Feb; 162(2):113-21. PubMed ID: 18164911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-energy phosphate metabolism in the frontal lobes of patients with panic disorder detected by phase-encoded 31P-MRS.
    Shioiri T; Kato T; Murashita J; Hamakawa H; Inubushi T; Takahashi S
    Biol Psychiatry; 1996 Oct; 40(8):785-93. PubMed ID: 8894072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton magnetic resonance spectroscopy of the hippocampus in patients with mild cognitive impairment: a pilot study.
    Franczak M; Prost RW; Antuono PG; Mark LP; Jones JL; Ulmer JL
    J Comput Assist Tomogr; 2007; 31(5):666-70. PubMed ID: 17895774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder.
    Atmaca M; Yildirim H; Ozdemir H; Koc M; Ozler S; Tezcan E
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):486-90. PubMed ID: 19531109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
    Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
    Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.